| human | Q5 |
| P496 | ORCID iD | 0000-0003-1921-954X |
| P214 | VIAF ID | 309571565 |
| P69 | educated at | Autonomous University of Barcelona | Q43452 |
| P108 | employer | Institut de Recerca Sant Pau (IR SANT PAU) | Q88101389 |
| P734 | family name | Padro | Q37548487 |
| Padro | Q37548487 | ||
| Padro | Q37548487 | ||
| P735 | given name | Teresa | Q2793617 |
| Teresa | Q2793617 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q37875384 | A generic operational strategy to qualify translational safety biomarkers |
| Q35994373 | A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients. |
| Q39301377 | Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature |
| Q60651996 | Aggregated low density lipoproteins decrease metalloproteinase-9 expression and activity in human coronary smooth muscle cells |
| Q45209695 | Aggregated low-density lipoprotein induces LRP1 stabilization through E3 ubiquitin ligase CHFR downregulation in human vascular smooth muscle cells. |
| Q34131953 | Analysis of incomplete gene expression dataset through protein-protein interaction information. |
| Q43766785 | Angiogenesis in patients with hematologic malignancies |
| Q60651906 | Antithrombotic therapy in obesity |
| Q40782701 | ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia |
| Q38765988 | Atheroma Burden and Morphology in Women. |
| Q42581726 | Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease |
| Q60651864 | Author reply |
| Q50983958 | CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts. |
| Q58419413 | CD3+/CD45+ and SMA-α+ circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event |
| Q60651855 | Changes in thrombus composition and profilin-1 release in acute myocardial infarction |
| Q60651891 | Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients |
| Q60651924 | Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques |
| Q53328449 | Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. |
| Q35121832 | Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) |
| Q60652070 | Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants |
| Q38389827 | Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study). |
| Q34197114 | Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk. |
| Q48848760 | Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues |
| Q43863903 | Efficacy and safety of thalidomide in patients with acute myeloid leukemia |
| Q51416435 | Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade. |
| Q54708650 | Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. |
| Q60652082 | Experimental hypothyroidism increases plasminogen activator inhibitor activity in rat plasma |
| Q60652001 | Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemia |
| Q60651949 | Extracorporeal Assays of Thrombosis |
| Q98199400 | Frail older adults show a distinct plasma microvesicle profile suggesting a prothrombotic and proinflammatory phenotype |
| Q43111611 | Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin. |
| Q35141623 | Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction |
| Q53396661 | Growing thrombi release increased levels of CD235a(+) microparticles and decreased levels of activated platelet-derived microparticles. Validation in ST-elevation myocardial infarction patients. |
| Q60651840 | High Levels of Antifibrinolytic Proteins Are Found in Plasma of Older Octogenarians With Cardiovascular Disease and Cognitive Decline |
| Q60651837 | High levels of TSP1+/CD142+ platelet-derived microparticles characterise young patients with high cardiovascular risk and subclinical atherosclerosis |
| Q60651900 | High-molecular-weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction |
| Q60652097 | Hyperlipemia, fibrinolysis and arteriosclerosis |
| Q51358287 | Incidence of diabetes and serum adipokines in Catalonian men: the ADIPOCAT study. |
| Q60652051 | Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia |
| Q60651985 | Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience |
| Q47869639 | Inflammation and hemostasis in older octogenarians: implication in 5-year survival. |
| Q33891946 | Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship? |
| Q46689453 | Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature |
| Q60651839 | Intake of cooked tomato sauce preserves coronary endothelial function and improves apolipoprotein A-I and apolipoprotein J protein profile in high-density lipoproteins |
| Q28214953 | Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma |
| Q53199151 | LDL accelerates monocyte to macrophage differentiation: Effects on adhesion and anoikis. |
| Q31068587 | LDL-induced impairment of human vascular smooth muscle cells repair function is reversed by HMG-CoA reductase inhibition |
| Q84595185 | LRP1 gene polymorphisms are associated with premature risk of cardiovascular disease in patients with familial hypercholesterolemia |
| Q35435106 | Lactobacillus plantarum CECT 7315/7316 intake modulates the acute and chronic innate inflammatory response |
| Q50933443 | Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells. |
| Q35536385 | Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk |
| Q57335957 | Lipoprotein(a) Levels in Familial Hypercholesterolemia |
| Q60651993 | Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain |
| Q33551146 | Low-density lipoproteins induce heat shock protein 27 dephosphorylation, oligomerization, and subcellular relocalization in human vascular smooth muscle cells. |
| Q37662861 | Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins |
| Q53117280 | Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients. |
| Q35905659 | Microparticle Shedding from Neural Progenitor Cells and Vascular Compartment Cells Is Increased in Ischemic Stroke |
| Q38801930 | Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry |
| Q60652014 | Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia |
| Q52535925 | Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries. |
| Q47323057 | Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions |
| Q60652026 | Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia |
| Q48627767 | Plasmin inhibitory effect of rat tissues: comparison with antiplasmin activity of plasma |
| Q112647695 | Platelet-released extracellular vesicles: the effects of thrombin activation |
| Q42324464 | Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). |
| Q54183092 | Polyphenol-enriched diet prevents coronary endothelial dysfunction by activating the Akt/eNOS pathway. |
| Q38379714 | Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study). |
| Q53659854 | Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation. |
| Q33991369 | Proteomic signature of thrombin-activated platelets after in vivo nitric oxide-donor treatment: coordinated inhibition of signaling (phosphatidylinositol 3-kinase-γ, 14-3-3ζ, and growth factor receptor-bound protein 2) and cytoskeleton protein [...] |
| Q48894840 | Qualitative and quantitative accuracy of ultrasound-based virtual histology for detection of necrotic core in human coronary arteries |
| Q60652076 | Quantification of Plasminogen Activators and Their Inhibitors in the Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic Disease |
| Q60652067 | Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries |
| Q34360887 | Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway. |
| Q35144562 | Retinol-binding protein 4 levels and susceptibility to ischaemic events in men. |
| Q60651846 | Roflumilast-induced Local Vascular Injury Is Associated with a Coordinated Proteome and Microparticle Change in the Systemic Circulation in Pigs |
| Q28069254 | Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis |
| Q60651989 | Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells |
| Q43648040 | Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia |
| Q38803424 | Systems biology approaches to understand the effects of nutrition and promote health |
| Q51529452 | Targeting the molecular mechanisms of ischemic damage: Protective effects of alpha-crystallin-B. |
| Q35562498 | Thalidomide for the Treatment of Acute Myeloid Leukemia |
| Q38567325 | The Role of Blood-Borne Microparticles in Inflammation and Hemostasis. |
| Q43961388 | The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells. |
| Q60652059 | Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology |
| Q51739310 | Translation strategy for the qualification of drug-induced vascular injury biomarkers. |
| Q35681250 | Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology |
| Q44373517 | UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1. |
| Q60652055 | Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma |
| Q38195537 | View of statins as antimicrobials in cardiovascular risk modification |
| Q60652108 | [Changes in the cholesterol-HDL fraction in experimental arteriosclerosis] |
| Q60652116 | [Pharmacological aspects of tienilic acid] |
| Q60651858 | rs11613352 Polymorphism (TT Genotype) Associates with a Decrease of Triglycerides and an Increase of HDL in Familial Hypercholesterolemia Patients |
| Q46425227 | rs1801275 Interleukin-4 receptor alpha polymorphism in familial hypercholesterolemia. |
Search more.